Short answer
NEOGEN CORP (NEOG) filed an 8-K current report with the SEC on July 30, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Fiscal 2026 fourth-quarter and full-year results released for year ended May 31, 2026.
NEOGEN CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal 2026 fourth-quarter and full-year results released for year ended May 31, 2026
- Detailed financial results contained in Exhibit 99.1, the accompanying earnings press release
- Disclosure furnished under Item 2.02 and excluded from Section 18 filing liability
Item EX-99.1 · Exhibit EX-99.1
- Q4 revenue $225.3M, down 0.1%, but core growth 4.3%; Food Safety core growth reached 5.8%, strongest since FY23
- Adjusted EBITDA $45.4M, up from $40.6M; margin expanded to 20.2% from 18.0% on pricing, mix, and cost savings
- Animal Safety revenue fell 8.2%, though sequential growth exceeded 7% as supply constraints largely eased
- Genomics divestiture targeted by end-FY27 first half for $160M proceeds, with approximately $140M net proceeds earmarked primarily for debt reduction
- FY27 guidance: revenue $880–$885M and Adjusted EBITDA $180–$182M, implying approximately 3% core growth; net debt stood at $608.2M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other NEOGEN CORP 8-K filings
Get the next NEOG 8-K as it lands
Follow NEOG for push alerts, or ask the research agent what this filing means.